Dr. Moses Owoicho Abah at World-Class Research Center “Digital biodesign and personalized healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia, Russia.
Dr. Moses Owoicho Abah is a passionate cancer researcher and molecular oncologist π§ͺ, currently pursuing a Ph.D. in Oncology/Radiation Therapy π at I.M. Sechenov First Moscow Medical University. With academic roots in Biochemistry, Bioinformatics, and Medical Biochemistry π§ , he specializes in RNA sequencing, immunoassays, and biomarker discovery. Dr. Abah has worked across leading institutions in Nigeria and Russia π³π¬π·πΊ, contributing to drug discovery, genomics, and personalized oncology. He brings deep expertise in data analysis using Python and R π, and his impactful research is published in Scopus-indexed journals π. His goal is to revolutionize cancer treatment globally.
Publication ProfileΒ
Google Scholar
Education
Dr. Moses Owoicho Abah’s educational path reflects his unwavering dedication to biomedical sciences and cancer research π§¬. He is currently pursuing a Ph.D. in Oncology/Radiation Therapy (2022β2025) at the Institute for Personalized Oncology, I.M. Sechenov First Moscow Medical University π·πΊ. He earned his M.Sc in Medical Biochemistry (2020β2022) from the University of Abuja π³π¬ and completed a Professional Program in Bioinformatics (2019β2020) at MIPT, Russia. His foundation lies in a B.Sc (Hons) in Biochemistry (2010β2015) from FUAM and a Senior School Certificate from GSS Otukpo (2002β2007) π. His journey blends science, research, and innovation.
Experience
Since February 2025, Dr. Moses Owoicho Abah has served as a Cancer Research Coordinator at the Genetics, Genomics, and Bioinformatics Department of the National Institute for Cancer Research and Treatment, Nigeria π³π¬. He collaborates closely with the Principal Investigator to uphold global research standards π, prepares proposals, budgets, protocols π, and handles informed consent and participant screening β
. Skilled in RStudio and Python ππ, he generates complex data visuals, manages study supplies, and maintains communication with stakeholders. He also revises and submits manuscripts to top journals π, contributing meaningfully to global cancer research.
Awards
Dr. Moses Owoicho Abah has received multiple prestigious awards for his excellence in research and academics π. In July 2021, he was honored with the Associate Fellow Award (CMRf-Bioinformatics) by the Royal Society of Clinical and Academic Researchers of Nigeria (ROSCARON) π§¬. In February 2020, he emerged Overall Best Scholar in Clinical Medicine, Chemistry & Biology during the Russian Open Door Scholarship competition π·πΊ. Earlier, in August 2018, he was conferred an Honorary Fellow Award by the Association of Economists and Statisticians of Nigeria (AESN) πβa testament to his cross-disciplinary brilliance.
Research FocusΒ
Dr. Moses Owoicho Abahβs research lies at the intersection of oncology, molecular medicine, and bioinformatics π§ͺ. His work focuses on cancer biology, particularly angiogenesis, cytokine signaling, and drug resistance mechanisms in lung and renal cancers ππ©Έ. He explores innovative therapies targeting biomarkers using comparative transcriptomics and RNA sequencing for precision medicine. Additionally, he investigates the toxicological effects of everyday compounds, such as triclosan π§Ό, and their impact on hormonal balance. His studies also include natural product pharmacology and the anti-diabetic potential of medicinal plants πΏ, bridging traditional medicine with modern therapeutic strategies.
Publication Top Notes